The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

The FDA doesn’t plan to execute a reorganization of the agency but will consolidate offices that handle travel, technology, ...

CR specifically examined the number of foodborne illnesses and deaths in 2024, the spread of the outbreaks and food recalls.

Among other things, Makary breaks some news here by stating, for the first time, that there will be no significant ...

Breeze Hunter thought she simply had a sinus infection she couldn’t kick. It was acute myeloid leukemia, a form of blood ...

The former head of Johnson & Johnson’s worldwide medtech business, Ashley McEvoy, has signed up to lead the insulin ...

Many doctors recommend routine follow-up tests for cancer patients after they’ve completed a course of treatment, with the ...

Following massive layoffs and cuts at the FDA, Makary’s plan for the agency is yet to fully unfold. But he has hinted at what ...

The FDA is currently reviewing Merck’s sBLA for Keytruda in head and neck cancer, with a target action date of June 23.

Spruce Biosciences has swept away 55% of its employees. The biotech took the action days after inking a deal for a former ...

The Upper East Regional Office of the Food and Drugs Authority (FDA), has cautioned sachet water producers against ...